Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: report of three cases

J Am Acad Dermatol. 2011 Aug;65(2):430-432. doi: 10.1016/j.jaad.2010.01.012.

Authors

Xiaoqing Zhao¹, Ruofei Shi¹, Xiaolong Jin², Jie Zheng³

Affiliations

¹ Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
² Department of Pathology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
³ Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Electronic address: jie-zheng2001@126.com.

PMID: 21763571
DOI: 10.1016/j.jaad.2010.01.012

No abstract available

Publication types

Letter

MeSH terms

Adult
Biopsy, Needle
Castleman Disease / diagnosis
Castleman Disease / drug therapy*
Castleman Disease / pathology*
Diagnosis, Differential
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Hyperpigmentation / diagnosis
Hyperpigmentation / drug therapy*
Hyperpigmentation / pathology*
Immunohistochemistry
Middle Aged
Prednisone / therapeutic use
Risk Assessment
Sampling Studies
Severity of Illness Index
Thalidomide / therapeutic use
Time Factors
Treatment Outcome

Substances

Thalidomide
Prednisone

Supplementary concepts

Multi-centric Castleman's Disease